drugset / Trial / NCT02057458

Blood Flow and Vascular Function in Cystic Fibrosis

NCT02057458

RandomizedCrossoverDouble-blindTreatment

Summary

Cystic fibrosis (CF) has many health consequences. A reduction in the ability to perform exercise in patients with CF is related to greater death rates, steeper decline in lung function, and more frequent lung infections. However, the physiological mechanisms for this reduced exercise capacity are unknown. The investigators laboratory recently published the first evidence of systemic vascular dysfunction in patients with CF. Therefore, it is reasonable to suspect that the blood vessels are involved with exercise intolerance in CF. This study will look at how 1) blood flow and 2) artery function contribute to exercise capacity in CF.

Timeline

Start
2014-04
Primary completion
2018-07
Completion
2018-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 20 mg Oral
Subject Sildenafil Unknown 50 mg Oral

Indications